Article thumbnail

Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis

By Natchimuthu Santhi and Sekar Aishwarya

Abstract

A crucial virulence factor for intracellular Mycobacterium tuberculosis survival is Protein kinase G (PknG), a eukaryotic-like serinethreonine protein kinase expressed by pathogenic mycobacteria that blocks the intracellular degradation of mycobacteria in lysosomes. Inhibition of PknG results in mycobacterial transfer to lysosomes. Withania somnifera, a reputed herb in ayurvedic medicine, comprises a large number of steroidal lactones known as withanolides which show various pharmacological activities. We describe the docking of 26 withanferin and 14 withanolides from Withania somnifera into the three dimensional structure of PknG of M. tuberculosis using GLIDE. The inhibitor binding positions and affinity were evaluated using scoring functions- Glidescore. The withanolide E, F and D and Withaferin - diacetate 2 phenoxy ethyl carbonate were identified as potential inhibitors of PknG. The available drug molecules and the ligand AX20017 showed hydrogen bond interaction with the aminoacid residues Glu233 and Val235. In addition to Val235 the other amino acids, Gly237, Gln238 and Ser239 are important for withanolide inhibitor recognition via hydrogen bonding mechanisms

Topics: Hypothesis
Publisher: Biomedical Informatics
OAI identifier: oai:pubmedcentral.nih.gov:3169209
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). 12: 229 [PMID: 15830846] Edited by P Kangueane Citation: Aishwarya & Santhi.
  2. (2006). Clin Infect Dis.
  3. (2001). Nat Rev Mol Cell Biol.
  4. (2005). Trends Cell Biol.